{"id":"cvp","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression (neutropenia, anemia, thrombocytopenia)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Alopecia"},{"rate":null,"effect":"Peripheral neuropathy"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Hemorrhage"}]},"_chembl":{"chemblId":"CHEMBL514392","moleculeType":"Small molecule","molecularWeight":"473.30"},"_dailymed":{"setId":"fa951d50-b79c-4161-8c81-fcf386b0964e","title":"TYLENOL EXTRA STRENGTH, TRAVEL BASIX (ACETAMINOPHEN) TABLET, COATED TYLENOL EXTRA STRENGTH, CVP HEALTH (ACETAMINOPHEN) TABLET, COATED TYLENOL EXTRA STRENGTH (ACETAMINOPHEN) TABLET, COATED [LIL' DRUG STORE PRODUCTS, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"CVP is a combination chemotherapy regimen where cyclophosphamide acts as an alkylating agent, vincristine inhibits microtubule formation, and prednisone provides immunosuppression. This triple-agent approach targets rapidly dividing cells and is commonly used in hematologic malignancies. The regimen has been a standard treatment option for decades, particularly in lymphoid cancers.","oneSentence":"CVP is a chemotherapy regimen combining cyclophosphamide, vincristine, and prednisone to suppress cancer cell growth through multiple cytotoxic and immunosuppressive mechanisms.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:29:58.765Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic lymphocytic leukemia (CLL)"},{"name":"Non-Hodgkin's lymphoma"},{"name":"Hodgkin's lymphoma"}]},"trialDetails":[{"nctId":"NCT07483151","phase":"","title":"Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","enrollment":110},{"nctId":"NCT07480863","phase":"PHASE2","title":"Treatment of BTKi+Hi-CVP Regimen for Previously Untreated MZL","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2025-10-01","conditions":"Marginal Zone Lymphoma(MZL)","enrollment":65},{"nctId":"NCT06549595","phase":"PHASE3","title":"A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-08-07","conditions":"Untreated Follicular Lymphoma","enrollment":1018},{"nctId":"NCT01679119","phase":"PHASE2","title":"Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy","status":"COMPLETED","sponsor":"University College, London","startDate":"2013-10","conditions":"Diffuse Large B Cell Lymphoma","enrollment":129},{"nctId":"NCT06091254","phase":"PHASE3","title":"A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2023-12-12","conditions":"Follicular Lymphoma (FL)","enrollment":822},{"nctId":"NCT06045247","phase":"PHASE2","title":"Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-01-05","conditions":"Large B-cell Lymphoma","enrollment":40},{"nctId":"NCT07419048","phase":"","title":"Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2026-02-02","conditions":"Inferior Vena Cava Imaging","enrollment":50},{"nctId":"NCT06689215","phase":"","title":"Comparison of Noninvasive vs. Invasive Hemodynamic Measurements","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nihon Kohden","startDate":"2024-10-21","conditions":"Heart Failure, Congestive","enrollment":30},{"nctId":"NCT06097364","phase":"PHASE3","title":"A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2023-11-14","conditions":"Follicular Lymphoma (FL)","enrollment":733},{"nctId":"NCT04680728","phase":"","title":"Venous Congestion and Organ Dysfunction.","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2020-10-06","conditions":"Venous Congestion, Organ Dysfunction Syndrome","enrollment":185},{"nctId":"NCT06180902","phase":"NA","title":"Comparing Fluid Responsiveness Assessment Methods in Patients With Impaired Consciousness","status":"RECRUITING","sponsor":"Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology","startDate":"2024-01-16","conditions":"Hypotension, Cognitive Impairment","enrollment":222},{"nctId":"NCT07226479","phase":"NA","title":"Non-invasive Venous Pressure Estimation","status":"RECRUITING","sponsor":"Yale University","startDate":"2026-01-06","conditions":"Cardiac Intensive Care","enrollment":40},{"nctId":"NCT07354841","phase":"NA","title":"Safety and Performance Evaluation of CPB Venous and Arterial Cannulas","status":"RECRUITING","sponsor":"Eurosets S.r.l.","startDate":"2025-10-21","conditions":"Cardiac Surgery, Heart Surgery, Cardiopulmonary Bypass","enrollment":80},{"nctId":"NCT07345559","phase":"NA","title":"Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock","status":"NOT_YET_RECRUITING","sponsor":"CMC Ambroise Paré","startDate":"2026-03-15","conditions":"Cardiogenic Shock","enrollment":406},{"nctId":"NCT07303855","phase":"NA","title":"Effectiveness of Goal-Directed Fluid Therapy Guided by Cardiac Index Versus Central Venous Pressure in Major Abdominal Surgery Patients in the ICU.","status":"RECRUITING","sponsor":"Indonesia University","startDate":"2025-12-01","conditions":"Elective Major Abdominal Surgery","enrollment":60},{"nctId":"NCT07285187","phase":"","title":"Venous Congestion And Delirium After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative, Venous Congestion, Postoperative Delirium (POD)","enrollment":120},{"nctId":"NCT07286643","phase":"NA","title":"Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2026-01-01","conditions":"Cirrhosis, Liver, Cirrhotic Cardiomyopathy, Septic Shock","enrollment":140},{"nctId":"NCT03780660","phase":"","title":"Diagnostic Accuracy of the Central Venous Pressure (CVP) Variation to Predict Fluid Responsiveness in Spontaneously Breathing Patients","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2019-03-05","conditions":"Breathing","enrollment":68},{"nctId":"NCT07232277","phase":"","title":"Venous Congestion and Cardiac Surgery-Associated Acute Kidney Injury","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-10-15","conditions":"Intraoperative, Venous Congestion, Cardiac Surgery-associated Acute Kidney Injury","enrollment":114},{"nctId":"NCT07179705","phase":"NA","title":"Using a Hypotension Prediction Index to Prevent Low Blood Pressure During Dialysis in ICU Patients","status":"RECRUITING","sponsor":"Chulalongkorn University","startDate":"2025-10-10","conditions":"Intradialytic Hypotension, Intensive Care Unit ICU, Hemodialysis Patients","enrollment":46},{"nctId":"NCT07222813","phase":"NA","title":"Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)","status":"NOT_YET_RECRUITING","sponsor":"Echosens","startDate":"2026-01-15","conditions":"Heart Failure, Heart Failure - NYHA II - IV","enrollment":149},{"nctId":"NCT01650701","phase":"PHASE3","title":"A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma","status":"COMPLETED","sponsor":"The Lymphoma Academic Research Organisation","startDate":"2012-02","conditions":"Follicular Lymphoma","enrollment":1030},{"nctId":"NCT06885073","phase":"NA","title":"Non-invasive Central Venous Pressure Estimation in Pediatric Patients","status":"RECRUITING","sponsor":"Compremium AG","startDate":"2025-03-10","conditions":"Central Venous Pressure","enrollment":100},{"nctId":"NCT07009132","phase":"","title":"Cholate Clearance in Fontan and Heart Failure","status":"RECRUITING","sponsor":"HepQuant, LLC","startDate":"2025-08-04","conditions":"Fontan, Right Heart Failure","enrollment":75},{"nctId":"NCT05058404","phase":"PHASE3","title":"Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Italiana Linfomi - ETS","startDate":"2021-12-01","conditions":"Follicular Lymphoma","enrollment":605},{"nctId":"NCT07136532","phase":"","title":"Prediction of Fluid Responsiveness in Paediatric Patients With Septic Shock Using Carotid Doppler Ultrasonography and Echocardiography","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-09-01","conditions":"Septic Shock, Echocardiography Guided Fluid Management","enrollment":50},{"nctId":"NCT07132697","phase":"NA","title":"The Efficacy of Intravenous Amino Acids in Reducing the Occurrence of AKI After Live Donor Liver Transplant","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2025-08-25","conditions":"Liver Transplant; Complications, AKI - Acute Kidney Injury","enrollment":100},{"nctId":"NCT02818218","phase":"","title":"Superior Vena Cava and Its Relationship to Central Venous Pressure Measurements in Liver Transplantation","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2016-07-01","conditions":"Liver Failure","enrollment":58},{"nctId":"NCT03651154","phase":"NA","title":"Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2018-09-28","conditions":"Liver Neoplasms, Hepatectomy, Blood Transfusion","enrollment":440},{"nctId":"NCT06700798","phase":"PHASE2","title":"Orelabrutinib Combined With Rituximab Versus R-CVP in the Untreated MZL： A Randomized, Open Phase II Trial","status":"RECRUITING","sponsor":"Fei Li","startDate":"2024-12-01","conditions":"Marginal Zone Lymphoma(MZL)","enrollment":90},{"nctId":"NCT06851585","phase":"","title":"Failure of First-attempt Insertion and Analysis of Practices Related to Peripheral Intravenous Catheters in the Emergency Department:","status":"COMPLETED","sponsor":"Poitiers University Hospital","startDate":"2025-04-03","conditions":"Catheterization, Catheterization, Peripheral, Catheters","enrollment":4312},{"nctId":"NCT05855954","phase":"NA","title":"Application of CLCVP Technique in Early Intervention of CSA-AKI","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2023-05-01","conditions":"Acute Kidney Injury","enrollment":200},{"nctId":"NCT06967142","phase":"","title":"Fluid Responsiveness Through the Corrected Carotid Flow Time, Before and After Sternotomy","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-01-01","conditions":"Coronary Artery Disease","enrollment":45},{"nctId":"NCT01476787","phase":"PHASE3","title":"Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma","status":"COMPLETED","sponsor":"Celgene","startDate":"2011-12-29","conditions":"Follicular Lymphoma","enrollment":1030},{"nctId":"NCT06959732","phase":"PHASE2","title":"Zanubrutinib Combined With G-CVP in Previously Untreated FL","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2025-01-01","conditions":"Follicular Lymphoma ( FL)","enrollment":40},{"nctId":"NCT06166875","phase":"","title":"Accuracy of IVCCI as a Measure of CVP","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-09-15","conditions":"IVC Collapsibility Index","enrollment":160},{"nctId":"NCT06833333","phase":"NA","title":"IVC Collapsibility Index or CVP as a Predictor of Fluid Responsiveness in Pediatric Sepsis","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2025-09-15","conditions":"Sepsis, Septic Shock, Perforated Viscus","enrollment":50},{"nctId":"NCT04156451","phase":"NA","title":"Effect of Fluid Deresuscitation With Central Venous Pressure Target 0-4 mmHg in Septic Shock Patients","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2019-11-14","conditions":"Septic Shock","enrollment":44},{"nctId":"NCT06937918","phase":"NA","title":"Effect of Dynamic Arterial Elastance and Assisted Fluid Management Software Guided Resuscitation in Septic Shock: Pilot Study","status":"RECRUITING","sponsor":"Mahidol University","startDate":"2025-04-23","conditions":"Critical Illness, Fluid Over-load, Dynamic Arterial Elastance","enrollment":60},{"nctId":"NCT01303887","phase":"PHASE3","title":"A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients","status":"COMPLETED","sponsor":"University of Liverpool","startDate":"2009-10","conditions":"Follicular Lymphoma","enrollment":680},{"nctId":"NCT06905015","phase":"NA","title":"Stroke Volume Variation Versus Central Venous Pressure Guidance for Reducing Perioperative Blood Loss During Open Liver Resection","status":"RECRUITING","sponsor":"Warangkana Lapisatepun","startDate":"2024-11-25","conditions":"Liver Tumor; Surgery, Primary Liver Tumor, Metastatic Liver, Primary Liver Cancer","enrollment":74},{"nctId":"NCT05980494","phase":"NA","title":"Lung Ultrasound Score and Inferior Vena Cava Diameter Compared to Pulse Pressure Variation","status":"COMPLETED","sponsor":"Fayoum University Hospital","startDate":"2022-09-13","conditions":"Sepsis, Critical Illness","enrollment":150},{"nctId":"NCT03853031","phase":"NA","title":"Transesophageal Echocardiology Measured Left Ventricular End Diastolic Area As Guide for Fluid Therapy in Major Oncosurgeries","status":"COMPLETED","sponsor":"Rajiv Gandhi Cancer Institute & Research Center, India","startDate":"2019-01-06","conditions":"Fluid Therapy DURING SURGERY","enrollment":60},{"nctId":"NCT06776666","phase":"","title":"Pulse Pressure Variation Vs. Central Venous Pressure for Fluid Management in Intracranial Tumor Surgery","status":"COMPLETED","sponsor":"Pamukkale University","startDate":"2024-04-03","conditions":"Brain Tumor Adult, Pulse Pressure Variation, Central Venous Pressure","enrollment":42},{"nctId":"NCT05441696","phase":"","title":"Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients","status":"ENROLLING_BY_INVITATION","sponsor":"Nihon Kohden","startDate":"2022-06-01","conditions":"Congestive Heart Failure","enrollment":65},{"nctId":"NCT04180202","phase":"","title":"Comparison of Non-invasive Vs. Invasive Hemodynamic Measurements","status":"TERMINATED","sponsor":"Nihon Kohden","startDate":"2020-01-16","conditions":"Heart Failure，Congestive","enrollment":8},{"nctId":"NCT02406092","phase":"PHASE3","title":"Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2015-10-13","conditions":"Non-Hodgkin Lymphoma","enrollment":139},{"nctId":"NCT06594289","phase":"NA","title":"Evaluation of the Safety and Effectiveness of Pringle Method Combined With IVC Flow Limiting and Blocking Method in Laparoscopic Hepatectomy Based on Non-restrictive Fluid Therapy Strategy","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-09-15","conditions":"Liver Tumor","enrollment":220},{"nctId":"NCT06568744","phase":"NA","title":"Fluid Intolerance Signals as Safety Limits to Prevent Fluid-induced Harm During Septic Shock Resuscitation","status":"RECRUITING","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2024-08-22","conditions":"Septic Shock","enrollment":62},{"nctId":"NCT06595667","phase":"NA","title":"Fluid Responsiveness in Posterior Fossa Tumor Resection: PPV and CVP Guidance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chiang Mai University","startDate":"2024-09-02","conditions":"Posterior Fossa Tumor, Brain Tumor Adult","enrollment":50},{"nctId":"NCT06524622","phase":"","title":"VExUS Combined With CVP to Predict Clinical Outcomes in Sepsis Participants","status":"RECRUITING","sponsor":"The Second People's Hospital of Yibin","startDate":"2024-07-01","conditions":"Sepsis, Acute Kidney Injury","enrollment":120},{"nctId":"NCT06440161","phase":"","title":"Association of Intraoperative Haemodynamic and Postoperative Complications in Type A Aortic Dissection Surgery","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2023-10-01","conditions":"Acute Kidney Injury","enrollment":543},{"nctId":"NCT03817853","phase":"PHASE4","title":"An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2019-02-26","conditions":"Advanced Follicular Lymphoma","enrollment":114},{"nctId":"NCT05048199","phase":"NA","title":"Hemodynamic Effects of Pressure-regulated Volume Control Mode in Patients With Diastolic Dysfunction Undergoing Radical Cystectomy","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2021-11-30","conditions":"Radical Cystectomy","enrollment":76},{"nctId":"NCT06026475","phase":"NA","title":"Role of Goal Directed Fluid Therapy in Enhanced Recovery After Surgery in Gastro-intestinal Oncosurgeries","status":"COMPLETED","sponsor":"Rajiv Gandhi Cancer Institute & Research Center, India","startDate":"2023-07-13","conditions":"Fluid Loss, Enhanced Recovery","enrollment":60},{"nctId":"NCT04005105","phase":"NA","title":"Acute Post-cardiac Surgery Renal Failure: Prevention Through Individualized Intensive Hemodynamic Management","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2019-10-14","conditions":"Acute Kidney Injury","enrollment":98},{"nctId":"NCT05393128","phase":"NA","title":"The Effect of Different Positions in Children After Cardiac Surgery","status":"COMPLETED","sponsor":"Acibadem University","startDate":"2022-03-17","conditions":"Infant ALL","enrollment":78},{"nctId":"NCT01088750","phase":"PHASE4","title":"Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Christine Mauz-Körholz","startDate":"2009-11-01","conditions":"Lymphoma","enrollment":225},{"nctId":"NCT05487924","phase":"NA","title":"Stroke Volume Variation- Guided Hemodynamic Therapy Versus Oxygen Extraction Ratio-guided Hemodynamic Therapy","status":"UNKNOWN","sponsor":"Beijing Tongren Hospital","startDate":"2023-12-30","conditions":"Goal-directed Fluid Therapy","enrollment":610},{"nctId":"NCT01099254","phase":"","title":"Internal Jugular Vein Cross Sectional Area","status":"COMPLETED","sponsor":"University of Iowa","startDate":"2007-08","conditions":"Central Venous Pressure","enrollment":38},{"nctId":"NCT01225757","phase":"NA","title":"Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC","status":"WITHDRAWN","sponsor":"University of Nebraska","startDate":"2010-11","conditions":"Peritoneal Neoplasms, Echocardiography Guided Fluid Management","enrollment":""},{"nctId":"NCT05968001","phase":"","title":"Obinutuzumab in Chinese Real-world Patients With iNHL","status":"NOT_YET_RECRUITING","sponsor":"Affiliated Hospital of Nantong University","startDate":"2023-07-20","conditions":"Lymphomas Non-Hodgkin's B-Cell","enrollment":400},{"nctId":"NCT01925131","phase":"PHASE1","title":"S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2014-06-13","conditions":"Acute Leukemias of Ambiguous Lineage, B-cell Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia","enrollment":50},{"nctId":"NCT05826795","phase":"","title":"Cost-effectiveness of EGDT Using FloTrac/EV1000","status":"UNKNOWN","sponsor":"Khon Kaen University","startDate":"2023-04-01","conditions":"Coronary Artery Disease","enrollment":60},{"nctId":"NCT03940144","phase":"NA","title":"Effect of SVV-guided Fluid Therapy on Outcomes After Major Abdominal Surgery","status":"COMPLETED","sponsor":"Beijing Tongren Hospital","startDate":"2019-05-15","conditions":"Goal-directed Fluid Therapy","enrollment":110},{"nctId":"NCT02579525","phase":"NA","title":"Targeted Tissue Perfusion Versus Macrocirculatory-guided Standard Care in Patients With Septic Shock","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2016-05","conditions":"Shock; Septic, Critical Illness","enrollment":200},{"nctId":"NCT05612529","phase":"","title":"Fluid Responseveness in Sepsis and Its Correlation to CVP","status":"TERMINATED","sponsor":"Assiut University","startDate":"2022-04-01","conditions":"Septic Shock","enrollment":45},{"nctId":"NCT04592406","phase":"","title":"Data on the Prevention of Complications of Prophylactic Intravenous Hydration in Patients With eGFR < 30","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2018-12-01","conditions":"Acute Kidney Injury (Nontraumatic), Contrast-induced Nephropathy","enrollment":443},{"nctId":"NCT00115700","phase":"PHASE3","title":"Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma","status":"COMPLETED","sponsor":"Trans Tasman Radiation Oncology Group","startDate":"2000-02","conditions":"Follicular Lymphoma","enrollment":150},{"nctId":"NCT03372135","phase":"","title":"Assessment of POCD After Steep Trendelenburg Position and CO2 Pneumoperitoneum With Cerebral Oxygen","status":"COMPLETED","sponsor":"RenJi Hospital","startDate":"2017-01-01","conditions":"Postoperative Cognitive Dysfunction","enrollment":147},{"nctId":"NCT01332968","phase":"PHASE3","title":"A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2011-07-06","conditions":"Non-Hodgkin's Lymphoma","enrollment":1401},{"nctId":"NCT05131867","phase":"PHASE2","title":"Management of Cerebral Vascular Spasm in Posttraumatic Subarachnoid Hemorrhage Using Combination Therapy","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2021-11-24","conditions":"Oral Nimodipine, Milrinone, Vascular Spasm After Traumatic Subarachnoidhaemorrhage","enrollment":30},{"nctId":"NCT05144451","phase":"NA","title":"Transcranial Doppler During Liver Transplantation","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2021-11-28","conditions":"Liver Transplantation, Ultrasonography, Doppler, Transcranial, Complication, Postoperative","enrollment":100},{"nctId":"NCT05222074","phase":"","title":"Effect of CVP and IOH on AKI and AKD","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2016-06-01","conditions":"Acute Kidney Injury, Acute Kidney Disease","enrollment":5127},{"nctId":"NCT00384111","phase":"PHASE3","title":"Phase 3 Study of Zevalin Following R-CVP in Previously Untreated Patients With Follicular Non Hodgkin's Lymphoma (NHL)","status":"TERMINATED","sponsor":"Spectrum Pharmaceuticals, Inc","startDate":"2006-10","conditions":"Follicular Lymphoma, Lymphoma, Follicular","enrollment":26},{"nctId":"NCT05033704","phase":"NA","title":"Effect of Human Plasma Protein Transfusion With and Without Crystalloids During Major Liver Resection Surgeries","status":"UNKNOWN","sponsor":"Hamad Medical Corporation","startDate":"2019-09-09","conditions":"Coagulation; Intravascular, Fluid Electrolyte Disorders","enrollment":48},{"nctId":"NCT04998253","phase":"EARLY_PHASE1","title":"Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2","status":"COMPLETED","sponsor":"Unidad Temporal COVID-19 en Centro Citibanamex","startDate":"2020-10-01","conditions":"Hypoxic Pulmonary Vasoconstriction, Hypoxemia, Acute Respiratory Distress Syndrome","enrollment":24},{"nctId":"NCT01427114","phase":"PHASE2","title":"R-CVP for the Treatment of Non-conjunctival Ocular Adnexal MALT Lymphoma (OAML)","status":"COMPLETED","sponsor":"Konkuk University Medical Center","startDate":"2011-07-01","conditions":"Lymphoma","enrollment":33},{"nctId":"NCT03402971","phase":"","title":"The Right Heart During and After Pregnancy - an Echocardiographic Study","status":"UNKNOWN","sponsor":"Gero Bunniger","startDate":"2017-11-02","conditions":"Pregnancy Related","enrollment":1000},{"nctId":"NCT04219150","phase":"NA","title":"Cardiometry Versus Fluid and Catheter Treatment Trial (FACTT Lite) on Fluid Management in Acute Respiratory Distress Syndrome Patients","status":"COMPLETED","sponsor":"Tanta University","startDate":"2020-01-10","conditions":"ARDS, Fluid Management, Cardiometry","enrollment":70},{"nctId":"NCT04659681","phase":"NA","title":"Role of Lung Ultrasonography in Detecting Extravascular Lung Water in Major Oncosurgeries","status":"COMPLETED","sponsor":"Rajiv Gandhi Cancer Institute & Research Center, India","startDate":"2020-01-01","conditions":"Extravascular Lung Water","enrollment":120},{"nctId":"NCT02548910","phase":"NA","title":"Phlebotomy to Prevent Blood Loss in Major Hepatic Resections","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2016-04","conditions":"Liver Neoplasms, Hepatectomy","enrollment":62},{"nctId":"NCT03262480","phase":"NA","title":"The Stroke Volume Optimization of Goal Directed Fluid Therapy During Radical Cystectomy","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2017-09-01","conditions":"Radical Cystectomy","enrollment":172},{"nctId":"NCT03296891","phase":"NA","title":"Point of Care Ultrasonography In The Management of Shock: A Pilot Study","status":"COMPLETED","sponsor":"Western University, Canada","startDate":"2017-09-10","conditions":"Shock, Hypotension","enrollment":50},{"nctId":"NCT03929055","phase":"NA","title":"Efficacy of High Velocity Nasal Insufflation","status":"UNKNOWN","sponsor":"University of Milan","startDate":"2018-01-01","conditions":"Acute Respiratory Failure, Diaphragmatic Function, Esophageal Pressure","enrollment":25},{"nctId":"NCT02865733","phase":"PHASE3","title":"Study of Remodulin® in Pediatric Pulmonary Hypertension With Single Ventricular Physiology After Fontan Surgery","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2016-08-01","conditions":"Pulmonary Hypertension","enrollment":36},{"nctId":"NCT00894907","phase":"NA","title":"Early Goal-directed Volume Resuscitation in Severe Acute Pancreatitis","status":"COMPLETED","sponsor":"Technical University of Munich","startDate":"2009-08-01","conditions":"Acute Pancreatitis","enrollment":190},{"nctId":"NCT03337386","phase":"NA","title":"Subclavian Versus Inferior Vena Cava Collapsibility Indices.","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2017-11-12","conditions":"Hemodynamic Instability","enrollment":64},{"nctId":"NCT04292951","phase":"NA","title":"Early Goal Directed Therapy in Cardiac Surgery","status":"COMPLETED","sponsor":"Khon Kaen University","startDate":"2020-01-01","conditions":"Postoperative Outcome, ICU Stay","enrollment":80},{"nctId":"NCT04257006","phase":"NA","title":"The Effects of Oxiris on Systemic Inflammation and Endothelial dysFunction","status":"UNKNOWN","sponsor":"St. Petersburg State Pavlov Medical University","startDate":"2020-08-17","conditions":"Acute Kidney Injury Due to Circulatory Failure (Disorder)","enrollment":50},{"nctId":"NCT04517409","phase":"NA","title":"Goal-directed Hemodynamic Therapy in Patiens Undergoing Major Hepatic Resection","status":"COMPLETED","sponsor":"Castilla-La Mancha Health Service","startDate":"2015-11-05","conditions":"Hemodynamic Monitoring","enrollment":45},{"nctId":"NCT01889069","phase":"PHASE3","title":"A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2013-07-31","conditions":"Lymphoma","enrollment":159},{"nctId":"NCT04092608","phase":"NA","title":"Restrictive vs Goal Directed Fluid Therapy During Hepatobiliary Surgery","status":"COMPLETED","sponsor":"Erasme University Hospital","startDate":"2019-09-04","conditions":"Liver Surgery","enrollment":40},{"nctId":"NCT04265014","phase":"NA","title":"Comparison of Goal-directed and Liberal Fluid Management","status":"WITHDRAWN","sponsor":"Bakirkoy Dr. Sadi Konuk Research and Training Hospital","startDate":"2020-01-01","conditions":"Goal-Directed Fluid Therapy, Hemodynamic Monitoring, Fluid Management","enrollment":""},{"nctId":"NCT01406041","phase":"","title":"Disturbance of Water and Sodium Metabolism After Surgery of Sellar Lesions, and Correspond Clinical Strategy","status":"UNKNOWN","sponsor":"Southern Medical University, China","startDate":"2011-02","conditions":"The Patients Suffered With Sellar Diseases, The Fluid and Electrolyte Imbalance Happened After Surgery","enrollment":350},{"nctId":"NCT03519165","phase":"NA","title":"Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery","status":"COMPLETED","sponsor":"Tata Medical Center","startDate":"2016-06","conditions":"Ovarian Cancer","enrollment":145},{"nctId":"NCT02162771","phase":"PHASE3","title":"To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan","status":"COMPLETED","sponsor":"Celltrion","startDate":"2014-07-14","conditions":"Lymphoma, Follicular","enrollment":140},{"nctId":"NCT01673230","phase":"NA","title":"Hemodynamic Indices Predictive of a Beneficial Response to Fluid Expansion in Case of Hemodynamic Failure After Cardiac Surgery With Altered Preoperative Ejection Fraction (LVEF≤45%)","status":"COMPLETED","sponsor":"Rennes University Hospital","startDate":"2012-09","conditions":"Ventricular Dysfunction","enrollment":50},{"nctId":"NCT04191408","phase":"NA","title":"Predictive Ability of PEEP Induced Changes in CVP to Predict Volume Responsiveness in Mechanically Ventilated Patients After Major Abdominal Surgery","status":"UNKNOWN","sponsor":"University Hospital Dubrava","startDate":"2019-11-01","conditions":"Surgery, Critical Illness, Cardiac Output, Low","enrollment":60},{"nctId":"NCT00624650","phase":"PHASE2","title":"Hemodynamics and Extravascular Lung Water in Acute Lung Injury","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2008-02","conditions":"Acute Lung Injury","enrollment":33}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20021210","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20030625","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"19990127","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"19980127","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20190206","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20170426","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20250417","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"19951012","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20181003","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20161214","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"19950920","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20180530","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20151218","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"19960912","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20180112","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"19930412","type":"ORIG","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20071220","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20130605","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20021127","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"19990723","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"19981029","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20031119","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"19980508","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"19970714","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"19980123","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20181221","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"19950901","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20121116","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"19950209","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20180705","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20160809","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"19930917","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20180530","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20150914","type":"SUPPL","sponsor":"BAYER HEALTHCARE LLC","applicationNumber":"NDA019658"},{"date":"20181002","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA021394"},{"date":"20150407","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA021394"},{"date":"20220110","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA021394"},{"date":"20110425","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA021394"},{"date":"20160315","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA021394"},{"date":"20090519","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA021394"},{"date":"20080611","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA021394"},{"date":"20150105","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA021394"},{"date":"20230221","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA021394"},{"date":"20180418","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA021394"},{"date":"20170721","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA021394"},{"date":"20100901","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA021394"},{"date":"20170330","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA021394"},{"date":"20051221","type":"ORIG","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA021394"},{"date":"20040827","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20030521","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20020419","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20000426","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"19990820","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20230417","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"19981022","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20160128","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20100204","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20190415","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20140730","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20171012","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20070131","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20001010","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20211103","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20000907","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"19991007","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20160429","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20230515","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20200227","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20151117","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20211207","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20180102","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"19980114","type":"ORIG","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20140715","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20170913","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20140415","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20120921","type":"SUPPL","sponsor":"PERRIGO R AND D","applicationNumber":"ANDA077349"},{"date":"20221115","type":"SUPPL","sponsor":"PERRIGO R AND D","applicationNumber":"ANDA077349"},{"date":"20060322","type":"SUPPL","sponsor":"PERRIGO R AND D","applicationNumber":"ANDA077349"},{"date":"20080116","type":"SUPPL","sponsor":"PERRIGO R AND D","applicationNumber":"ANDA077349"},{"date":"20221115","type":"SUPPL","sponsor":"PERRIGO R AND D","applicationNumber":"ANDA077349"},{"date":"20221115","type":"SUPPL","sponsor":"PERRIGO R AND D","applicationNumber":"ANDA077349"},{"date":"20050621","type":"ORIG","sponsor":"PERRIGO R AND D","applicationNumber":"ANDA077349"},{"date":"20020117","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA074091"},{"date":"19970513","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA074091"},{"date":"20200909","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA074091"},{"date":"19940718","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA074091"},{"date":"20210709","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA074091"},{"date":"19921210","type":"ORIG","sponsor":"OHM LABS","applicationNumber":"ANDA074091"},{"date":"20210709","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA074091"},{"date":"20021016","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA074091"},{"date":"20000621","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA074091"},{"date":"20001228","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA074091"},{"date":"19980227","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA074091"},{"date":"19930616","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA074091"},{"date":"20210709","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA074091"},{"date":"20060912","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA074091"}],"publicationCount":3966,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"CVP","genericName":"CVP","companyName":"SCRI Development Innovations, LLC","companyId":"scri-development-innovations-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CVP is a chemotherapy regimen combining cyclophosphamide, vincristine, and prednisone to suppress cancer cell growth through multiple cytotoxic and immunosuppressive mechanisms. Used for Chronic lymphocytic leukemia (CLL), Non-Hodgkin's lymphoma, Hodgkin's lymphoma.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}